Medical Cannabis Market, by Point of Sale (Dispensaries, Online Pharmacy, Hospital Pharmacy), by Active Ingredient (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)) and by Therapeutic Application (Pain, Arthritis, Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications), Other Applications) - Global Trends, and Forecast to 2025

Global Medical Cannabis Market - Insights

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. The various economies are involved in the activities to legalize the export of medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis market. For instance, in January 2018, the Government of Australia allowed cannabis producers in the region to export medicinal cannabis and cannabis products in the global market.

The global medical cannabis market is valued at US$ 3,520.7 million in 2017 and is expected to witness a CAGR of 24.4% over the forecast period (2017 – 2025).

Figure 1. Global Medical Cannabis Market Share (%), by Region, 2017

medical cannabis market

Source: Coherent Market Insights Analysis (2017)

Increase in the legalization of medicinal cannabis in various economies is expected to augment the market growth

Increasing approval of medicinal cannabis products and growing research and development activities in the medical cannabis market are expected to support the growth of the market. For instance, in March 2017, German parliament signed a law allowing the medicinal use of the cannabis plant by allowing the healthcare professionals to prescribe the medicinal cannabis products to the patients suffering from severe health issues such as chronic pain, vomiting, and nausea. Moreover, excessive cannabis consumption is known to induce tachycardia and can increase the risk of heart attack, notably for users with existing heart disease or arrhythmias and thus it is restraining growth of the market.

Potential medical cannabis markets other than the U.S. include Canada, Israel, Australia, and Spain. Mexico is also in process to consider the legalization of cannabis. For instance, in February 2016, Medical Marijuana, Inc. launched the HempMeds Mexico- a CBD hemp oil product in the Mexico. With the launch of HempMeds Mexico, company is intended to expand its cannabis business in the Latin America, by establishing the labs, manufacturing, sales and distribution facilities in the Mexico, in coming years.  Other economies are expected to consider legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis are obtained through extensive research. Czech Republic, in 2013, legalized medical marijuana for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other severe disease indications. Moreover, the law allows patients with marijuana prescription to purchase the medicinal marijuana from pharmacies. However, cultivation of marijuana in not allowed in the country, and thereby suppliers need to import medicinal cannabis from other economies. This implies that there is a huge potential for growth of the medicinal cannabis industry in pharmaceutical and biotechnology companies.  

In Middle East, among other GCC economies, only Israel has approved the medical cannabis product. Furthermore, in Africa region, Lesotho and Malawi (South Africa) government has granted the license for medicinal marijuana in 2017. For instance, In June 2017, Verve Dynamics, a Cape Town-based alternative medicines company received license from the Government of Lesotho to cultivate the cannabidiol (CBD) medicinal cannabis. Verve Dynamics intends to cultivate and produce medicinal cannabis products and export these product in South Africa.

Expansion of medicinal cannabis product by various manufacturers is a prominent factor fueling market growth

Medicinal cannabis manufacturers in the U.S. are actively focusing on expansion of their medicinal cannabis product business. For instance, in July 2016, Insys Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) approval for dronabinol oral solution- Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol. The Syndros is indicated to be used in the treatment of anorexia associated with weight loss among patients suffering from AIDS and those suffering from cancer chemotherapy-induced nausea and vomiting. Moreover, in January 2018, Apria, Inc. entered into a distribution agreement with Cannabis Wheaton, to supply 60,000 kilograms of the cannabis products between January 2018 and February 2022. The agreement allows Aphria to expand its brand through Cannabis Wheaton’s strong distribution network in Canada. 

Some of the key players operating in the global medical cannabis market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, and Medical Marijuana Inc.

According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.

Market Dynamics

According to the Medical Marijuana, Inc., an estimated size of the legal marijuana industry in the U.S. was US$ 7.1 billion in 2016 with increase of 25% Y-o-Y. In 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medical cannabis market. However, lack of formulation of a comprehensive law pertaining to medical marijuana in some states inhibits patient access to the drug.

Market Taxonomy

This report segments the global medicinal cannabis on the basis of point of sale, active ingredient and therapeutic application. On the basis of point of sale, the global medical cannabis market is classified into dispensaries, online pharmacy, and hospital pharmacy. Active ingredients of medicinal cannabis include tetrahydrocannabinol (THC) and Cannabidiol (CBD). Therapeutic Application categorized into pain, arthritis, neurological disease, and other applications.

Key features of the study:

  • This report provides in-depth analysis of medicinal cannabis in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global medicinal cannabis for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc and Medical Marijuana Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
  • The global medicinal cannabis for medical sector market report caters to various stakeholders in this industry including investors, suppliers, medicinal cannabis device manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the medicinal cannabis for medical sector market

Detailed Segmentation:

  • Global Medical Cannabis Market, By Point of Sale:
    • Dispensaries
    • Online Pharmacy
    • Hospital Pharmacy
  • Global Medical Cannabis Market, By Active Ingredient:
    • Tetrahydrocannabinol (THC)
    • Cannabidiol (CBD)
  • Global Medical Cannabis Market, By Therapeutic Application:
    • Pain
    • Arthritis
    • Neurological Disease
      • Epilepsy
      • Multiple Sclerosis
      • Other Neurological Applications
    • Other Applications
  • Global Medical Cannabis Market, By Geography:
    • North America
      • By Country:
        • U.S.
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Canada
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
    • Europe
      • By Country:
        • U.K.
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Germany
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Italy
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Spain
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • France
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Rest of Europe
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
    • Asia-Pacific (Australia)
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
    • Latin America
      • By Country:
        • Chile
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Argentina
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
        • Rest of Latin America
          • By Active Ingredient:
            • Tetrahydrocannabinol (THC)
            • Cannabidiol (CBD)
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
    • Middle East (Israel)
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
    • Africa
      • By Point of Sale:
        • Dispensaries
        • Online Pharmacy
        • Hospital Pharmacy
      • By Active Ingredient:
        • Tetrahydrocannabinol (THC)
        • Cannabidiol (CBD)
      • By Therapeutic Application:
        • Pain
        • Arthritis
        • Neurological Disease
          • Epilepsy
          • Multiple Sclerosis
          • Other Neurological Applications
        • Other Applications
  • Company Profiles
    • BOL Pharma*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Tilray
    • Medreleaf Corporation
    • Aurora Cannabis, Inc.
    • Canopy Growth Corporation
    • Insys Therapeutics, Inc.
    • Aphria, Inc.
    • MGC Pharmaceuticals Limited
    • GW Pharmaceuticals, plc
    • Medical Marijuana Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Point of Sale
      • Market Snippet By Active Ingredient
      • Market Snippet By Therapeutic Application
      • Market Snippet By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Promotional Activities
    • Product Approvals
    • Application of Cannabis to Medicinal Cannabis
  4. Global Medical Cannabis Market, By Point of Sale, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Dispensaries
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Hospital Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  5. Global Medical Cannabis Market, By Active Ingredient, 2017 - 2025 (USD Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Tetrahydrocannabinol (THC)
      • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
    • Cannabidiol (CBD)
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  6. Global Medical Cannabis Market, By Therapeutic Application, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, 2017 - 2025
      • Segment Trends
    • Pain
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Arthritis
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Neurological Disease
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
        • Epilepsy
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
        • Multiple Sclerosis
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
        • Other Neurological Applications
          • Introduction
          • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
    • Other Applications
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2017 - 2025, (US$ Million)
  7. Global Medical Cannabis Market, By Regions, 2017 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2025 (%)
      • Y-O-Y Growth Analysis, For Regions, 2017 - 2025
    • North America
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017-2025, (US$ Million)
        • U.S.
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Canada
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
    • Europe
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017-2025, (US$ Million)
        • U.K.
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Germany
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Italy
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • France
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Spain
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Rest of Europe
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
    • Asia Pacific (Australia)
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017-2025, (US$ Million)
    • Latin America
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017-2025, (US$ Million)
        • Chile
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Argentina
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
        • Rest of Latin America
          • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
    • Africa
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
    • Middle East (Israel)
      • Market Share Analysis, 2017 and 2025 (%)
      • Market Size and Forecast, By Point of Sale, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Active Ingredient, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Therapeutic Application, 2017-2025, (US$ Million)
      • Market Size and Forecast, By Country, 2017-2025, (US$ Million)
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis (3x3 Matrix)
    • Company Profiles
      • BOL Pharma
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Tilray
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medreleaf Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Aurora Cannabis, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Canopy Growth Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Insys Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Aphria, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • MGC Pharmaceuticals Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • GW Pharmaceuticals, plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Medical Marijuana Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 31 figures on "Medical Cannabis Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]marketinsights.com

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.